{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:37:02Z","timestamp":1784759822273,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nutritional status, infections, inflammation and extrahepatic organ dysfunction are critical factors for the progression of chronic liver disease. Chemerin is an immune-metabolically and chemotactically active adipokine and we hypothesized that it is associated with disease severity and prognosis in patients with advanced decompensated cirrhosis. Therefore, we measured serum concentrations of chemerin in a prospectively characterized cohort of 80 patients with decompensated cirrhosis and ascites and assessed the associations with markers of disease severity and short-term outcome at 28 days. In a subset of patients (n\u2009=\u200940), ascitic fluid chemerin was determined. Advanced liver disease was associated with decreased serum but not ascitic chemerin levels. Serum chemerin correlated with markers of hepatic function (total bilirubin, albumin, INR) and inversely correlated with indicators of portal hypertension (platelet count, gastrointestinal bleeding) but not with extrahepatic organ failure and systemic inflammation. Patients presenting with acute-on-chronic liver failure or infection did not exhibit altered serum or ascitic fluid chemerin concentrations. However, serum chemerin levels below 87\u2009ng\/ml predicted an increased risk for mortality or liver transplantation within 28 days independently of MELD and infections. We conclude that low serum chemerin is an independent adverse prognostic factor in patients with advanced decompensated cirrhosis.<\/jats:p>","DOI":"10.1038\/s41598-018-27543-6","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T09:42:44Z","timestamp":1528796564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Paul","family":"Horn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"von Loeffelholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Forkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Stengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Reuken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Aschenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stallmach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5576-6914","authenticated-orcid":false,"given":"Tony","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,18]]},"reference":[{"key":"27543_CR1","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1210\/en.2007-0175","volume":"148","author":"K Bozaoglu","year":"2007","unstructured":"Bozaoglu, K. et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148, 4687\u20134694, https:\/\/doi.org\/10.1210\/en.2007-0175 (2007).","journal-title":"Endocrinology"},{"key":"27543_CR2","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1210\/jc.2008-1833","volume":"94","author":"K Bozaoglu","year":"2009","unstructured":"Bozaoglu, K. et al. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. The Journal of clinical endocrinology and metabolism 94, 3085\u20133088, https:\/\/doi.org\/10.1210\/jc.2008-1833 (2009).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"27543_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1530\/EJE-13-0112","volume":"169","author":"S D\u00f6cke","year":"2013","unstructured":"D\u00f6cke, S. et al. Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. European journal of endocrinology\/European Federation of Endocrine Societies 169, 547\u2013557, https:\/\/doi.org\/10.1530\/EJE-13-0112 (2013).","journal-title":"European journal of endocrinology \/ European Federation of Endocrine Societies"},{"key":"27543_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.yexmp.2013.07.009","volume":"95","author":"S Krautbauer","year":"2013","unstructured":"Krautbauer, S. et al. Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver. Experimental and molecular pathology 95, 199\u2013205, https:\/\/doi.org\/10.1016\/j.yexmp.2013.07.009 (2013).","journal-title":"Experimental and molecular pathology"},{"key":"27543_CR5","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1100\/2011\/290142","volume":"11","author":"M Scotece","year":"2011","unstructured":"Scotece, M. et al. Beyond fat mass: exploring the role of adipokines in rheumatic diseases. TheScientificWorldJournal 11, 1932\u20131947, https:\/\/doi.org\/10.1100\/2011\/290142 (2011).","journal-title":"TheScientificWorldJournal"},{"key":"27543_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.yexmp.2015.01.010","volume":"98","author":"K Eisinger","year":"2015","unstructured":"Eisinger, K., Krautbauer, S., Wiest, R., Weiss, T. S. & Buechler, C. Reduced serum chemerin in patients with more severe liver cirrhosis. Experimental and molecular pathology 98, 208\u2013213, https:\/\/doi.org\/10.1016\/j.yexmp.2015.01.010 (2015).","journal-title":"Experimental and molecular pathology"},{"key":"27543_CR7","doi-asserted-by":"publisher","first-page":"11294","DOI":"10.3390\/ijms150711294","volume":"15","author":"K Imai","year":"2014","unstructured":"Imai, K. et al. Impact of serum chemerin levels on liver functional reserves and platelet counts in patients with hepatocellular carcinoma. International journal of molecular sciences 15, 11294\u201311306, https:\/\/doi.org\/10.3390\/ijms150711294 (2014).","journal-title":"International journal of molecular sciences"},{"key":"27543_CR8","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1084\/jem.20030382","volume":"198","author":"V Wittamer","year":"2003","unstructured":"Wittamer, V. et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. The Journal of experimental medicine 198, 977\u2013985, https:\/\/doi.org\/10.1084\/jem.20030382 (2003).","journal-title":"The Journal of experimental medicine"},{"key":"27543_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/iub.1242","volume":"66","author":"A Mattern","year":"2014","unstructured":"Mattern, A., Zellmann, T. & Beck-Sickinger, A. G. Processing, signaling, and physiological function of chemerin. IUBMB life 66, 19\u201326, https:\/\/doi.org\/10.1002\/iub.1242 (2014).","journal-title":"IUBMB life"},{"key":"27543_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1530\/EJE-13-0098","volume":"169","author":"JP Chamberland","year":"2013","unstructured":"Chamberland, J. P., Berman, R. L., Aronis, K. N. & Mantzoros, C. S. Chemerin is expressed mainly in pancreas and liver, is regulated by energy deprivation, and lacks day\/night variation in humans. European journal of endocrinology\/European Federation of Endocrine Societies 169, 453\u2013462, https:\/\/doi.org\/10.1530\/EJE-13-0098 (2013).","journal-title":"European journal of endocrinology \/ European Federation of Endocrine Societies"},{"key":"27543_CR11","doi-asserted-by":"publisher","first-page":"e58709","DOI":"10.1371\/journal.pone.0058709","volume":"8","author":"M Banas","year":"2013","unstructured":"Banas, M. et al. Chemerin is an antimicrobial agent in human epidermis. PloS one 8, e58709, https:\/\/doi.org\/10.1371\/journal.pone.0058709 (2013).","journal-title":"PloS one"},{"key":"27543_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cytogfr.2011.11.004","volume":"22","author":"B Bondue","year":"2011","unstructured":"Bondue, B., Wittamer, V. & Parmentier, M. Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine & growth factor reviews 22, 331\u2013338, https:\/\/doi.org\/10.1016\/j.cytogfr.2011.11.004 (2011).","journal-title":"Cytokine & growth factor reviews"},{"key":"27543_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.febslet.2008.01.023","volume":"582","author":"M Takahashi","year":"2008","unstructured":"Takahashi, M. et al. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS letters 582, 573\u2013578, https:\/\/doi.org\/10.1016\/j.febslet.2008.01.023 (2008).","journal-title":"FEBS letters"},{"key":"27543_CR14","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1210\/en.2009-1098","volume":"151","author":"MC Ernst","year":"2010","unstructured":"Ernst, M. C., Issa, M., Goralski, K. B. & Sinal, C. J. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 151, 1998\u20132007, https:\/\/doi.org\/10.1210\/en.2009-1098 (2010).","journal-title":"Endocrinology"},{"key":"27543_CR15","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.2337\/db10-0362","volume":"59","author":"M Becker","year":"2010","unstructured":"Becker, M. et al. Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet. Diabetes 59, 2898\u20132903, https:\/\/doi.org\/10.2337\/db10-0362 (2010).","journal-title":"Diabetes"},{"key":"27543_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2015.02.005","author":"R Pohl","year":"2015","unstructured":"Pohl, R. et al. Resolvin E1 and chemerin C15 peptide do not improve rodent non-alcoholic steatohepatitis. Experimental and molecular pathology, https:\/\/doi.org\/10.1016\/j.yexmp.2015.02.005 (2015).","journal-title":"Experimental and molecular pathology"},{"key":"27543_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/obr.12333","volume":"17","author":"M Bekaert","year":"2016","unstructured":"Bekaert, M., Verhelst, X., Geerts, A., Lapauw, B. & Calders, P. Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review. Obesity reviews: an official journal of the International Association for the Study of Obesity 17, 68\u201380, https:\/\/doi.org\/10.1111\/obr.12333 (2016).","journal-title":"Obesity reviews: an official journal of the International Association for the Study of Obesity"},{"key":"27543_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1365-2893.2009.01174.x","volume":"17","author":"M Kukla","year":"2010","unstructured":"Kukla, M. et al. Chemerin, vaspin and insulin resistance in chronic hepatitis C. Journal of viral hepatitis 17, 661\u2013667, https:\/\/doi.org\/10.1111\/j.1365-2893.2009.01224.x (2010).","journal-title":"Journal of viral hepatitis"},{"key":"27543_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/eci.12695","volume":"47","author":"R Pohl","year":"2017","unstructured":"Pohl, R. et al. Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis. European journal of clinical investigation 47, 7\u201318, https:\/\/doi.org\/10.1111\/eci.12695 (2017).","journal-title":"European journal of clinical investigation"},{"issue":"1426-1437","key":"27543_CR20","doi-asserted-by":"publisher","first-page":"1437 e1421","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau, R. et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 144(1426\u20131437), 1437 e1421\u20131429, https:\/\/doi.org\/10.1053\/j.gastro.2013.02.042 (2013).","journal-title":"Gastroenterology"},{"key":"27543_CR21","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the, L. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. Journal of hepatology 53, 397\u2013417, https:\/\/doi.org\/10.1016\/j.jhep.2010.05.004 (2010).","DOI":"10.1016\/j.jhep.2010.05.004"},{"key":"27543_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1365-2265.2009.03664.x","volume":"72","author":"J Weigert","year":"2010","unstructured":"Weigert, J. et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clinical endocrinology 72, 342\u2013348, https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03664.x (2010).","journal-title":"Clinical endocrinology"},{"key":"27543_CR23","doi-asserted-by":"publisher","first-page":"e57802","DOI":"10.1371\/journal.pone.0057802","volume":"8","author":"MM Herenius","year":"2013","unstructured":"Herenius, M. M. et al. Anti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation. PloS one 8, e57802, https:\/\/doi.org\/10.1371\/journal.pone.0057802 (2013).","journal-title":"PloS one"},{"key":"27543_CR24","doi-asserted-by":"publisher","DOI":"10.3109\/10641963.2013.827697","author":"P Gu","year":"2013","unstructured":"Gu, P., Jiang, W., Lu, B. & Shi, Z. Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patients. Clinical and experimental hypertension, https:\/\/doi.org\/10.3109\/10641963.2013.827697 (2013).","journal-title":"Clinical and experimental hypertension"},{"key":"27543_CR25","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/00000658-198012000-00008","volume":"192","author":"JM Henderson","year":"1980","unstructured":"Henderson, J. M. et al. Analysis of Twenty-three plasma proteins in ascites. The depletion of fibrinogen and plasminogen. Annals of surgery 192, 738\u2013742 (1980).","journal-title":"Annals of surgery"},{"key":"27543_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3349\/ymj.2017.58.2.319","volume":"58","author":"DY Cheon","year":"2017","unstructured":"Cheon, D. Y. et al. Serum Chemerin Levels are Associated with Visceral Adiposity, Independent of Waist Circumference, in Newly Diagnosed Type 2 Diabetic Subjects. Yonsei Med J 58, 319\u2013325, https:\/\/doi.org\/10.3349\/ymj.2017.58.2.319 (2017).","journal-title":"Yonsei Med J"},{"key":"27543_CR27","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/oby.21735","volume":"25","author":"S Zylla","year":"2017","unstructured":"Zylla, S. et al. Serum chemerin is associated with inflammatory and metabolic parameters-results of a population-based study. Obesity 25, 468\u2013475, https:\/\/doi.org\/10.1002\/oby.21735 (2017).","journal-title":"Obesity"},{"key":"27543_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5114\/pjp.2017.69687","volume":"68","author":"M Kajor","year":"2017","unstructured":"Kajor, M. et al. Hepatic chemerin mRNA in morbidly obese patients with nonalcoholic fatty liver disease. Pol J Pathol 68, 117\u2013127, https:\/\/doi.org\/10.5114\/pjp.2017.69687 (2017).","journal-title":"Pol J Pathol"},{"key":"27543_CR29","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1002\/oby.21674","volume":"24","author":"M Bekaert","year":"2016","unstructured":"Bekaert, M. et al. Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity. Obesity 24, 2544\u20132552, https:\/\/doi.org\/10.1002\/oby.21674 (2016).","journal-title":"Obesity"},{"key":"27543_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10059-012-0012-7","volume":"33","author":"AA Alfadda","year":"2012","unstructured":"Alfadda, A. A. et al. Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: adipose depot specificity and gender dimorphism. Molecules and cells 33, 591\u2013596, https:\/\/doi.org\/10.1007\/s10059-012-0012-7 (2012).","journal-title":"Molecules and cells"},{"key":"27543_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1507\/endocrj.EJ12-0201","volume":"60","author":"M Takahashi","year":"2013","unstructured":"Takahashi, M. et al. Decreased serum chemerin levels in male Japanese patients with type 2 diabetes: sex dimorphism. Endocrine journal 60, 37\u201344 (2013).","journal-title":"Endocrine journal"},{"key":"27543_CR32","doi-asserted-by":"publisher","unstructured":"Blaszak, J. et al. High serum chemerin level in CKD patients is related to kidney function, but not to its adipose tissue overproduction. Renal failure, 1\u20136, https:\/\/doi.org\/10.3109\/0886022X.2015.1040707 (2015).","DOI":"10.3109\/0886022X.2015.1040707"},{"key":"27543_CR33","first-page":"1","volume":"3","author":"BA Zabel","year":"2014","unstructured":"Zabel, B. A. et al. Chemerin regulation and role in host defense. American journal of clinical and experimental immunology 3, 1\u201319 (2014).","journal-title":"American journal of clinical and experimental immunology"},{"key":"27543_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1209-5","volume":"20","author":"P Horn","year":"2016","unstructured":"Horn, P. et al. Chemerin in peritoneal sepsis and its associations with glucose metabolism and prognosis: a translational cross-sectional study. Critical care 20, 39, https:\/\/doi.org\/10.1186\/s13054-016-1209-5 (2016).","journal-title":"Critical care"},{"key":"27543_CR35","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.4049\/jimmunol.1002352","volume":"187","author":"P Kulig","year":"2011","unstructured":"Kulig, P. et al. Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsins. Journal of immunology 187, 1403\u20131410, https:\/\/doi.org\/10.4049\/jimmunol.1002352 (2011).","journal-title":"Journal of immunology"},{"key":"27543_CR36","doi-asserted-by":"publisher","first-page":"e1002358","DOI":"10.1371\/journal.ppat.1002358","volume":"7","author":"B Bondue","year":"2011","unstructured":"Bondue, B. et al. ChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumonia. PLoS pathogens 7, e1002358, https:\/\/doi.org\/10.1371\/journal.ppat.1002358 (2011).","journal-title":"PLoS pathogens"},{"key":"27543_CR37","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.4049\/jimmunol.0901037","volume":"183","author":"S Luangsay","year":"2009","unstructured":"Luangsay, S. et al. Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. Journal of immunology 183, 6489\u20136499, https:\/\/doi.org\/10.4049\/jimmunol.0901037 (2009).","journal-title":"Journal of immunology"},{"key":"27543_CR38","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1084\/jem.20071601","volume":"205","author":"JL Cash","year":"2008","unstructured":"Cash, J. L. et al. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. The Journal of experimental medicine 205, 767\u2013775, https:\/\/doi.org\/10.1084\/jem.20071601 (2008).","journal-title":"The Journal of experimental medicine"},{"key":"27543_CR39","first-page":"13393","volume":"8","author":"J Ma","year":"2015","unstructured":"Ma, J., Niu, D. S., Wan, N. J., Qin, Y. & Guo, C. J. Elevated chemerin levels in synovial fluid and synovial membrane from patients with knee osteoarthritis. Int J Clin Exp Pathol 8, 13393\u201313398 (2015).","journal-title":"Int J Clin Exp Pathol"},{"key":"27543_CR40","doi-asserted-by":"publisher","first-page":"e57113","DOI":"10.1371\/journal.pone.0057113","volume":"8","author":"SS Fatima","year":"2013","unstructured":"Fatima, S. S., Bozaoglu, K., Rehman, R., Alam, F. & Memon, A. S. Elevated chemerin levels in Pakistani men: an interrelation with metabolic syndrome phenotypes. Plos One 8, e57113, https:\/\/doi.org\/10.1371\/journal.pone.0057113 (2013).","journal-title":"Plos One"},{"key":"27543_CR41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cca.2013.02.017","volume":"421","author":"MK Lee","year":"2013","unstructured":"Lee, M. K. et al. The association between chemerin and homeostasis assessment of insulin resistance at baseline and after weight reduction via lifestyle modifications in young obese adults. Clinica chimica acta; international journal of clinical chemistry 421, 109\u2013115, https:\/\/doi.org\/10.1016\/j.cca.2013.02.017 (2013).","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"key":"27543_CR42","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2009-2374","volume":"95","author":"H Sell","year":"2010","unstructured":"Sell, H. et al. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. The Journal of clinical endocrinology and metabolism 95, 2892\u20132896, https:\/\/doi.org\/10.1210\/jc.2009-2374 (2010).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"27543_CR43","doi-asserted-by":"publisher","first-page":"e0159142","DOI":"10.1371\/journal.pone.0159142","volume":"11","author":"V Rachakonda","year":"2016","unstructured":"Rachakonda, V. et al. Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis. Plos One 11, e0159142, https:\/\/doi.org\/10.1371\/journal.pone.0159142 (2016).","journal-title":"Plos One"},{"key":"27543_CR44","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/liv.13095","volume":"36","author":"T Bruns","year":"2016","unstructured":"Bruns, T. et al. The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection. Liver Int 36, 1133\u20131142, https:\/\/doi.org\/10.1111\/liv.13095 (2016).","journal-title":"Liver Int"},{"key":"27543_CR45","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh, R. N., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C. & Williams, R. Transection of the oesophagus for bleeding oesophageal varices. The British journal of surgery 60, 646\u2013649 (1973).","journal-title":"The British journal of surgery"},{"key":"27543_CR46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2003.50016","volume":"124","author":"R Wiesner","year":"2003","unstructured":"Wiesner, R. et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124, 91\u201396, https:\/\/doi.org\/10.1053\/gast.2003.50016 (2003).","journal-title":"Gastroenterology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27543-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27543-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27543-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T06:34:47Z","timestamp":1671604487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27543-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["27543"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-27543-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,18]]},"assertion":[{"value":"14 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9242"}}